MILAN, Italy & TOKYO--(BUSINESS WIRE)--Sorin Group, (Reuters Code: SORN.MI) (MIL:SRN), a global company and a leader in the treatment of cardiovascular diseases, announced today the Japanese approval and the market release of ISOLINETM1, its latest generation of defibrillation leads.
